In life, there is nothing to be afraid of, only many things to learn
Marie Curie
RESEARCH AND THERAPY FOR NEOPLASTIC HEMATOLOGIC DISORDERS

data center

Our Data Center is structured in five different offices that collaborate closely in order to attain the Foundation’s purposes

read more >
clinical trials

A clinical trial is an experimentation on human subjects intended to identify or verify the clinical outcomes of one or more experimental drugs

read more >
cooperation

In the research field, success is obtained through joint effort and tight collaboration among scientific institutions and groups involved in comparing their own experiences

read more >
WHO WE ARE

FONDAZIONE EUROPEAN MYELOMA NETWORK ITALY ONLUS (previously FO.NE.SA. ONLUS - Fondazione Neoplasie Sangue) is a non-profit foundation, wich fosters and finances scientific research while economically supporting patients and their families. Hematologic pathologies are the main field of activity, with close attention to multiple myeloma. For more than a decade, Fondazione EMN Italy Onlus has been a touchstone for physicians, researchers, and experts in the field who are involved in the study of this type of pathologies. The Foundation also supports whoever has to face long paths of therapy and recovery.

read more >

Prof. Mario Boccadoro
President of Fondazione EMN Italy Onlus
and his collaborators

WHO WE ARE

Prof. Mario Boccadoro
President of Fondazione EMN Italy Onlus
and his collaborators

FONDAZIONE EUROPEAN MYELOMA NETWORK ITALY ONLUS (previously FO.NE.SA. ONLUS - Fondazione Neoplasie Sangue) is a non-profit foundation, wich fosters and finances scientific research while economically supporting patients and their families. Hematologic pathologies are the main field of activity, with close attention to multiple myeloma. For more than a decade, Fondazione EMN Italy Onlus has been a touchstone for physicians, researchers, and experts in the field who are involved in the study of this type of pathologies. The Foundation also supports whoever has to face long paths of therapy and recovery.

read more >
OBJECTIVES ACHIEVED
34

New
therapy protocols
available for patients

new drugs administered to patients in clinical trials

10

articles published on journals of high scientific impact since 2012

30
85

abstracts selected for the main hematology conferences since 2012

news
Training Evolution About Multiple Myeloma - TEAMM
Training in multiple myeloma
11/27/2019

We are pleased to announce that the training course for the evaluation of multiple myeloma is now online. Users can register for free at the following website: http://www.teamm-fad.it/
read more >

EMN TRIALIST FORUM 2019
11th EMN Trialist Forum - Baveno (Italy)
09/29/2019

EMN will organize the 11th edition of the Trialist Forum in Baveno (VB) – Italy. This traditional event will take place on 29 and 30 September 2019. Fonesa has always supported valid initiatives in the clinical field, and the forum in Baveno will…

read more >
EMN20 INVESTIGATOR MEETING
KRd - transplant-ineligible patients
04/17/2019

The EMN20 (KRd vs Rd) is a study promoted by Fonesa. The investigator meeting with the Italian sites will take place in Milan, at the Ibis Centrale Hotel, close to the train station, from 9.00 to 13.00.

Italian investigators included in the…

read more >
read all the news >
news

COOKIES DISCLAIMER

This website uses cookies to improve your browsing experience. By continuing to browse this website, you agree to our use of cookies. Read the privacy policy

ACCEPT DON' T ACCEPT